BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Get Free Report) was the target of unusually large options trading on Monday. Stock investors acquired 2,478 call options on the stock. This is an increase of approximately 59% compared to the average volume of 1,554 call options. Analyst Ratings Changes Separately, Needham & Company LLC reiterated a “buy” rating […]